DJIA 17,356.87 288.00 1.69%
NASDAQ 4,644.31 96.48 2.12%
S&P 500 2,012.89 40.15 2.04%
market minute promo

CTI BioPharma Corp. (NASDAQ: CTIC)

2.36 0.15 (6.79%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CTIC $2.36 6.79%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.25
Previous Close $2.21
Daily Range $2.24 - $2.37
52-Week Range $1.69 - $4.25
Market Cap $353.6M
P/E Ratio -9.21
Dividend (Yield) $0.00 (0.0%)
Volume 1,910,222
Average Daily Volume 1,798,021
Current FY EPS -$0.54

Sector

Healthcare

Industry

Drugs

CTI BioPharma Corp. (CTIC) Description

CTI BioPharma Corp. Website: http://www.celltherapeutics.com/

News & Commentary Rss Feed

Why CTI BioPharma Corp. Stock Tumbled 10% in November

CTI BioPharma irritates shareholders by returning to its old habits and its stock pays the price.

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Insider Trading Alert - CSU, IRBT And CTIC Traded By Insiders

Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off

Incyte Building Blockbuster Drug One Disease At A Time

Insider Trading Alert - CTIC, SAM And DGI Traded By Insiders

CTI BioPharma's (CTIC) CEO James Bianco on Q3 2014 Results - Earnings Call Transcript

InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPha

InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma

Merrimack Does Well to License Marginal Cancer Drug to Baxter

Morning Market Movers

See More CTIC News...

CTIC's Top Competitors

CTIC $2.36 (6.79%)
Current stock: CTIC
AMGN $163.48 (2.53%)
Current stock: AMGN
GILD $102.40 (1.93%)
Current stock: GILD
BIIB $332.89 (2.39%)
Current stock: BIIB